Three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for chromone derivatives against HIV-1 protease using molecular field analysis (MFA) with genetic partial least square algorithms (G/PLS). Three different alignment methods: field fit, pharmacophore-based, and receptor-based were used to derive three MFA models. All models produced good predictive ability with high cross-validated r2 (r2cv), conventional r2, and predictive r2 (r2pred) values. The receptor-based MFA showed the best statistical results with r2cv = 0.789, r2 = 0.886, and r2pred = 0.995. The result obtained from the receptor-based model was compared with the docking simulation of the most active compound 21 in this chromone series to ...
There has been a tremendous progress in the development of anti-HIV therapies since the discovery of...
Aromatase inhibitors are the most important targets in treatment of estrogen-dependent cancers. In ...
Diarylpyrimidines (DAPYs), acting as HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs), ...
Three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for c...
Several protease inhibitors have reached the world market in the last fifteen years, dramatically im...
Three-dimensional quantitative structure-activity relationship (3D QSAR) and cluster analysis were a...
HIV protease inhibitors are one of the most important agents for the treatment of HIV infection. In ...
Multiple Quantitative Structure-Activity Relationship (QSAR) analysis is widely used in drug discove...
The Lamarckian genetic algorithm of AutoDock 3.0 has been used to dock 27 3(S)-amino-2(S)-hydroxyl-4...
AbstractTwo- and three-dimensional quantitative structure–activity relation (QSAR) models were gener...
A potential anti-Human Immunodeficiency Virus (HIV) agent with novel mode of action is urgently need...
The molecular modeling studies include quantitative structure activity relationship, IR spectra, and...
In spite of significant progress in anti-HIV-1 therapy, current antiviral chemotherapy still suffers...
A quantitative structure-activity relationship (QSAR) study on 48 peptidic HIV-1 protease inhibitors...
Three-dimensional Quantitative Structure Activity Relationship (3D-QSAR) has been derived for a set ...
There has been a tremendous progress in the development of anti-HIV therapies since the discovery of...
Aromatase inhibitors are the most important targets in treatment of estrogen-dependent cancers. In ...
Diarylpyrimidines (DAPYs), acting as HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs), ...
Three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for c...
Several protease inhibitors have reached the world market in the last fifteen years, dramatically im...
Three-dimensional quantitative structure-activity relationship (3D QSAR) and cluster analysis were a...
HIV protease inhibitors are one of the most important agents for the treatment of HIV infection. In ...
Multiple Quantitative Structure-Activity Relationship (QSAR) analysis is widely used in drug discove...
The Lamarckian genetic algorithm of AutoDock 3.0 has been used to dock 27 3(S)-amino-2(S)-hydroxyl-4...
AbstractTwo- and three-dimensional quantitative structure–activity relation (QSAR) models were gener...
A potential anti-Human Immunodeficiency Virus (HIV) agent with novel mode of action is urgently need...
The molecular modeling studies include quantitative structure activity relationship, IR spectra, and...
In spite of significant progress in anti-HIV-1 therapy, current antiviral chemotherapy still suffers...
A quantitative structure-activity relationship (QSAR) study on 48 peptidic HIV-1 protease inhibitors...
Three-dimensional Quantitative Structure Activity Relationship (3D-QSAR) has been derived for a set ...
There has been a tremendous progress in the development of anti-HIV therapies since the discovery of...
Aromatase inhibitors are the most important targets in treatment of estrogen-dependent cancers. In ...
Diarylpyrimidines (DAPYs), acting as HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs), ...